EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

Upcoming congress
EAACI
Hybrid Congress 2022
1 - 3 July 2022

UPCOMING EVENTS

    PAAM Digital 2021, Pediatric Allergy and Asthma Meeting
    12 - 13 November 2021
    Digital Event
    Save the date
    Winter School on Basic Immunology Research in Allergy and Clinical Immunology Hybrid 2022
    27 - 30 January 2022
    Semmering, Austria
    Save the date
ALL, PAI & CTA
Journals
EAACI Guidelines
Guidelines
Global Atlases
Books
Overview of active Task Forces
Task Forces
All webcasts from EAACI Meetings
Webcasts
Visit the EAACI Media Library
Media Library
All EAACI news
Newsletter
Important EAACI publications
Position Papers
Save the Date - EAACI Hybrid Congress 2022
6961w5Share
It is with great pleasure that we announce date and destination of the EAACI Hybrid Congress 2022! We look forward to seeing you all on 1-3 July 2022 in Prague, Czech Republic at the O2 universum, and digitally, under the motto "Common origins of allergy and chronic inflammatory diseases - One Health approach". We are eager to share with you the latest developments in basic, translational and clinical research in allergy, asthma and immunology, and as usual invite your personal valuable contribu...
Read the first edition of our EAACI Review!
22053m6Share
We invite you to read the very first edition of the "EAACI Review" - a collection of salient news, exciting testimonials from our EAACI Community, and important information about upcoming and past events. In this issue find the Public Outreach Task Force Cartoon video on COVID-10; work from the EAACI Task Force on Lipid Transfer Protein Allergy across Europe; the promotion of the Allergy College at the upcoming EAACI Hybrid Congress 2021, and much more. Do you have an important update to share ...
Access all our previous articles
& newsletters in PDF format.
EAACI Advocacy: Celebrating World Food Day 2021
2317h0Share
On this World Food Day 2021, EAACI wants to raise awareness of the burden of food allergy and the importance of creating solid plans for its prevention, diagnosis and care. Mo...
PAAM Digital 2021 granted 16 CME Credits!
432d1Share
We are glad to announce that the EAACI Pediatric Allergy and Asthma Meeting (PAAM Digital 2021) has been granted 16 European CME credits (ECMEC®s) by the European Accreditation Co...
Participate at the One-Day Meeting of the EAACI AllergoOncology WG on 18 November!
623d1Share
We would like to warmly invite you to register for the upcoming one-day Meeting of the AllergoOncology Working Group “Danger Signals, Inflammation in Allergy and Cancer” whic...
Allergopharma Award 2022 - Submit your application now
6451m3Share
EAACI and Allergopharma are pleased to announce the opening of applications for the EAACI – Allergopharma Research Award 2022.Apply now until November 17, 2021.The award recognis...
EAACI mourns the loss of Kai-Håkon Carlsen
3401m0Share
It is with great sadness that we inform you that Prof. Kai-Håkon Carlsen has passed away. Prof. Carlsen was Professor of Paediatrics (Paediatric respiratory medicine and allerg...
Apply now to the EAACI Fellowship 2022 Programme
9251m3Share
EAACI is pleased to announce the opening of the application period for the EAACI Research and Clinical Fellowships 2022.Applications are open until November 17, 2021. The EAACI Res...
ERS/EAACI statement on Adherence to International Adult Asthma Guidelines
6571m2Share
We invite you to read the ERS/EAACI statement on Adherence to International Adult Asthma Guidelines, taken from the ERS Congress pre-event programme. This presentation recites the ...
EAACI Job Centre - New External Positions
5862m4Share
EAACI supports medical professionals from the beginning of their studies and throughout their professional careers. Here you can find a selection of job opportunities.Consulta...
Next
Launch of the EAACI Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
21263m6Share
We are proud to announce the launch of the new EAACI Guidelines on Omalizumab for the treatment of Chronic Spontaneous Urticaria, a major scientific output of 2021 for the Academy....
EAACI Working Group on Primary Care’s survey of general practitioners: update
18204m3Share
In 2019, the EAACI Working Group on Primary Care invited EAACI members to work with us to identify the needs of European general medical practitioners (GPs) with regards to allergi...
EAACI Task Force on Conscious and rational use of antibiotics in allergic diseases
18644m4Share
Rational use of antibiotics has become an essential topic in clinical care, mainly because of emerging antimicrobial resistance which is a threat to global health. Patients with al...
NAS Junior Committee translation activity: EAACI needs YOU!
24425m9Share
The National Allergy Societies Junior Committee (NAS-JM) is a shared platform promoted by the EAACI National Allergy Societies Committee and Junior Member Assembly to increase the ...
EAACI Advocacy – Celebrating the World Day of Asthma
32165m3Share
With more than 350 million patients affected around the world, asthma prevalence and impact are on the rise, associated with environmental and lifestyle changes. Asthma is the mo...
Transitional deals available for EAACI Journals
23305m1Share
Aligned with the current effort of the scientific community towards higher  democratization of knowledge through the Open Access publishing model, EAACI and its partner publis...
EAACI Advocacy – Celebrating the International Day of Immunology with Top Research News
24296m5Share
On the International Day of Immunology, the European Academy of Allergy and Clinical Immunology would like to highlight three important topics revolving around current immunology r...
EAACI Advocacy - World Day for Safety and Health at Work
25286m5Share
EAACI Advocacy - World Day for Safety and Health at Work: every effort should be made to keep the workplace safe and healthy On the occasion of World Day for Safety and Health at ...
Previous
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel